News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Norak Biosciences, Inc. And Lundbeck Exercise Option On Transfluor(R) Screen



10/19/2005 5:11:44 PM

RESEARCH TRIANGLE PARK, N.C., Aug. 10 /PRNewswire/ -- Norak Biosciences, Inc. announced today that Lundbeck A/S has exercised its option to screen another of its G protein-coupled receptor (GPCR) targets of interest using Norak's Transfluor(R) technology. The option was part of the screening collaboration agreement signed December 19, 2002 between Norak and Lundbeck. Under the terms of the agreement Norak will develop a Transfluor cell line expressing the GPCR target of interest to Lundbeck and then screen this cell line at Norak on its high throughput imaging systems against a compound library of Lundbeck's choice. Financial terms were not disclosed.

Norak's Transfluor(R) technology is a patented, universal GPCR drug discovery technology designed to be the most direct and accurate method for screening potential drug candidates against GPCR targets, whether known or orphan. Transfluor(R) was licensed in 1999 by Norak from technology developed at Duke University Medical Center and represents the combined research into GPCR signaling pathways over several decades by Norak's scientific founders, Drs. Marc Caron, Robert Lefkowitz, and Larry Barak.

About Norak:

Norak Biosciences, Inc., headquartered in Research Triangle Park, NC, is a private biotechnology company. Norak is utilizing its proprietary Transfluor(R) technology to become a world leader in the discovery and development of drugs that regulate G protein-coupled receptors. For more information about Norak Biosciences, Inc., please visit the Company's website at http://www.norakbio.com/ .

Contact: Terry E. Willard Executive Vice President Norak Biosciences, Inc. 7030 Kit Creek Road Morrisville, NC 27560 Phone: 919-248-8000 ext. 8804 Fax: 919-248-8033 twillard@norakbio.com

Norak Biosciences, Inc.

CONTACT: Terry E. Willard, Executive Vice President of NorakBiosciences, Inc., +1-919-248-8000 ext. 8804, or Fax, +1-919-248-8033, ortwillard@norakbio.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES